PDSB
PDSB
NASDAQ · Biotechnology

Pds Biotechnology Corp

$0.98
-0.04 (-3.92%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,965.3% upside
Low Target $11.64
Average Target $20.24
High Target $22.20
Current Price $0.98
Current
$0.98
Target
$20.24
$11.64 $20.24 avg $22.20
Scenario Analysis
Bear Case
$11.64
1,087.8%
Low target
Base Case
$20.24
+1,965.3%
Avg target
Bull Case
$22.20
+2,165.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$1.79
-45.3% from high
52-Week Low
$0.20
+402.0% from low
Target vs 52W High
$20.24
+1,030.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%